Dexcom Inc
NASDAQ:DXCM
Dexcom Inc
NASDAQ:DXCM
Price:
124.34 USD
-9.91%
Market Closed
Updated:
Apr 28, 2024
Dexcom Inc
Research & Development
|
Dexcom Inc
Research & Development Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Dexcom Inc
NASDAQ:DXCM
|
Research & Development
-$505.8m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-27%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Research & Development
-$1.2B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-9%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Research & Development
-$1.4B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-5%
|
|
|
Stryker Corp
NYSE:SYK
|
Research & Development
-$1.3B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-9%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Research & Development
-$2.6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-7%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Research & Development
-$1B
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-20%
|
See Also
What is Dexcom Inc's Research & Development?
Research & Development
-505.8m
USD
-505.8m
USD
Based on the financial report for Dec 31, 2023, Dexcom Inc's Research & Development amounts to -505.8m USD.
What is Dexcom Inc's Research & Development growth rate?
Research & Development CAGR 10Y
-27%
-27%
Over the last year, the Research & Development growth was -4%. The average annual Research & Development growth rates for Dexcom Inc have been -12% over the past three years , -4% over the past five years , and -27% over the past ten years .
You don't have any saved screeners yet
